Certified by Founder Lodge
Stipple Bio
United States - Cambridge, MA
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Stipple Bio is a biotechnology company harnessing epitope-level precision to create targeted cancer therapies through our proprietary Pointillist Platform, which is designed to identify tumor
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 07 ,2026 | Series A | $100,000,000 |
GV (Google Ventures)
Nextech Invest
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
HexemBio | $10,400,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
E2 - Endovascular Engineering | $80,000,000 | (Apr 9, 2026)
GoSats - The simplest onramp to Digital Assets in India | $5,000,000 | (Apr 9, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
